AFJK Stock Forecast 2025-2026
Distance to AFJK Price Targets
AFJK Price Momentum
10 Quality Stocks Worth Considering Now
Researching Aimei Health (AFJK) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on AFJK and similar high-potential opportunities.
Latest AFJK Stock Price Targets & Analyst Predictions
AFJK has shown a year-to-date change of 2.8% and a 1-year change of 7.1%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for AFJK. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AFJK Analyst Ratings
AFJK Price Target Range
Latest AFJK Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AFJK.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
Aimei Health Technology Co., Ltd. (AFJK) Competitors
The following stocks are similar to Aimei Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Aimei Health Technology Co., Ltd. (AFJK) Financial Data
Aimei Health Technology Co., Ltd. has a market capitalization of $67.34M with a P/E ratio of 39.3x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of +3.5%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Aimei Health Technology Co., Ltd. (AFJK) Business Model
About Aimei Health Technology Co., Ltd.
Develops advanced health technology solutions.
Aimei Health Technology Co., Ltd. generates revenue by researching, developing, and producing innovative medical devices and wellness products aimed at improving patient care. The company operates in various healthcare sectors, selling diagnostic equipment, therapeutic devices, and digital health platforms to hospitals, clinics, and individual consumers.
With a strong emphasis on research and development, Aimei Health Technology is a key player in driving advancements in healthcare delivery. The company is positioned to address the growing global health demands, contributing to the modernization and efficiency of healthcare systems.
Aimei Health Technology Co., Ltd. (AFJK) Latest News & Analysis
Latest News
Aimei Health Technology (NASDAQ: AFJK) shares are down despite announcing a $1.6 billion SPAC merger with United Hydrogen Group, which will go public on Nasdaq under a new ticker.
Aimei Health's stock drop despite a $1.6 billion SPAC merger indicates investor skepticism, potentially signaling concerns over valuation or execution risks in the deal.
United Hydrogen Group plans to list on Nasdaq through a blank-check merger, valuing the company at $1.6 billion.
United Hydrogen Group's Nasdaq listing via a SPAC merger at a $1.6 billion valuation signals growth potential in the green energy sector, attracting investor interest and capital.
Frequently Asked Questions About AFJK Stock
What is Aimei Health Technology Co., Ltd.'s (AFJK) stock forecast for 2025?
Analyst forecasts for Aimei Health Technology Co., Ltd. (AFJK) are not currently available. The stock is trading at $11.00.
Is AFJK stock a good investment in 2025?
Analyst ratings for AFJK are not currently available. The stock is currently trading at $11.00. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AFJK stock?
Price predictions from Wall Street analysts for AFJK are not currently available. The stock is trading at $11.00.
What is Aimei Health Technology Co., Ltd.'s business model?
Aimei Health Technology Co., Ltd. generates revenue by researching, developing, and producing innovative medical devices and wellness products aimed at improving patient care. The company operates in various healthcare sectors, selling diagnostic equipment, therapeutic devices, and digital health platforms to hospitals, clinics, and individual consumers.
What is the highest forecasted price for AFJK Aimei Health Technology Co., Ltd.?
Price targets from Wall Street analysts for AFJK are not currently available. The stock is trading at $11.00.
What is the lowest forecasted price for AFJK Aimei Health Technology Co., Ltd.?
Price targets from Wall Street analysts for AFJK are not currently available. The stock is trading at $11.00.
What is the overall AFJK consensus from analysts for Aimei Health Technology Co., Ltd.?
Analyst ratings for AFJK are not currently available. The stock is trading at $11.00.
How accurate are AFJK stock price projections?
Stock price projections, including those for Aimei Health Technology Co., Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.